Page 131 - 2019年9月第30卷第17期

132（39）：13663-13665. [37] BACELAR AH，CARVALHO MA，PROENCA MF. Syn-
[25] SHIRUDE PS，SHABDIL R，SADLER C，et al. Azain- thesis and in vitro evaluation of substituted pyrimido[5，
doles：noncovalent DprE1 inhibitors from scaffold morph- 4-d]pyrimidines as a novel class of anti-mycobacterium tu-
ing efforts，kill mycobacterium tuberculosis and are effica- berculosis agents[J]. Eur J Med Chem，2010.DOI：10.1016/
cious in vivo[J]. J Med Chem，2013，56（23）：9701-9708. j.ejmech.2010.03.047.
[26] VELEZHEVA V，BRENNAN P，IVANOV P，et al. Synthe- [38] RAJU KS，REDDY SA，SABITHA G. Synthesis and bio-
sis and antituberculosis activity of indole-pyridine derived logical evaluation of 1H-pyrrolo[2，3-d]-pyridine-1，2，
hydrazides，hydrazide-hydrazones，and thiosemicarba- 3-triazole derivatives as novel anti-tubercular agents[J].
zones[J]. Bioorg Med Chem Lett，2015，26（3）：978-985. Bioorg Med Chem Lett，2018.DOI：10.1016/j.bmcl.2018.
[27] ELKHOLY YM，ALI KA，FARAG AM. Studies with pyr- 11.036.
azol-3-carboxylic acid hydrazide：the synthesis of new [39] HADJIKAKOU SK，HADJILIADIS N. Antiproliferative
pyrazolyloxadiazole and pyrazolyltriazole derivatives[J]. and anti-tumor activity of organotin compounds[J]. Coor
Pho Sul Sil Rela Ele，2006，181（9）：2037-2049. Chem Rev，2009，253（1/2）：235-249.
[28] ZAFER AK，GULHAN TZ，AHMET O，et al. New tri- [40] HUSSAIN H，BIBI N，ALHARRASI A，et al. Antitubercu-
azole and triazolothiadiazine derivatives as possible anti- losis and cytotoxic activities of triorganotin（Ⅳ）complex-
microbial agents[J]. Eur J Med Chem，2008.DOI：10.1016/ es[J]. C Chem Lett，2012，23（6），731-735.
j.ejmech.2007.03.019. [41] DASILVA A，DEALMEIDA M，DESOUZA M，et al. Bio-
[29] CLOUGH J，CHEN S，GORDIN EM，et al. Combinatorial logical activity and synthetic metodologies for the prepara-
modification of natural products：synthesis and in vitro tion of fluoroquinolones，a class of potent antibacterial
analysis of derivatives of thiazole peptide antibiotic agents[J]. Curr Med Chem，2003，10（1）：21-39.
GE2270 A：a-ring modifications[J]. Bioorg Med Chem- [42] VIEIRA LM，ALMEIDA MV，LOUREN MC，et al. Syn-
Lett，2003，13（20）：3409-3414. thesis and antitubercular activity of palladium and plati-
[30] PRESTON PN. Benzimidazoles and congeneric tricyclic num complexes with fluoroquinolones[J]. E J Med Chem，
compounds[M]. New Jersey：Wiley，1980：217-219. 2009.DOI：10.1016/j.ejmech.2009.05.001.
[31] JADHAV GR，SHAIKH MU，KALE RP，et al. SAR study [43] SCHNELL JR，DYSON HJ，WRIGHT PE. Structure，dy-
of clubbed [1，2，4]-triazolyl with fluorobenzimidazoles as namics，and catalytic function of dihydrofolate reductase
antimicrobial and antituberculosis agents[J]. Eur J Med [J]. Annu Rev Biophys Biomol Struct，2004，33（1）：119-
Chem，2009.DOI：10.1016/j.ejmech.2008.12.001. 140.
[32] GILL C，JADHAV G，SHAIKH M，et al. Clubbed [1，2，3] [44] BERMAN EM，WERBEL LM. The renewed potential for
triazoles by fluorine benzimidazole：a novel approach to folate antagonists incontemporary cancer chemotherapy
H37Rv inhibitors as a potential treatment for tuberculosis [J]. J Med Chem，1991，34（2）：479-485.
[J]. Bioorg Med Chem Lett，2008，18（23）：6244-6247. [45] TAWARI NR，BAG S，RAJU A，et al. Rational drug de-
[33] CHRISTOPHE M，RODRIGUEZ F，RIBEIRO A，et al. sign，synthesis and biological evaluation of dihydrofolate
Synthesis and evaluation of α-ketotriazolesand and α ，β- reductase inhibitors as antituberculosis agents[J]. Future
diketotriazoles asinhibitors of mycobacterium tuberculosis Med Chem，2015，7（8）：979-988.
[J]. Eur J Med Chem，2013.DOI：10.1016/j.ejmech.2013. [46] LUCKNER S，MACHUTTA C，TONGE P，et al. Crystal
06.042. structures of mycobacterium tuberculosis KasA show
[34] KERI RS，CHAND K，BUDAGUMPI S，et al. An over- mode of action within cell wall biosynthesis and its inhibi-
view of benzo[b]thiophene-based medicinal chemistry[J]. tion by thiolactomycin[J]. Structure，2009，17（7）：1004-
Eur J Med Chem，2017.DOI：10.1016/j.ejmech.2017.07. 1013.
038. [47] MAKAM P，KANKANALA R，PRAKASH A，et al. 2-
[35] MAHAJAN PS，NIKAM MD，NAWALE LU，et al. Syn- （2-hydrazinyl）thiazole derivatives：design，synthesis and
thesis and anti-tubercular activity of new benzo[b]thio- in vitro；antimycobacterial studies[J]. E J Med Chem，
phenes[J]. ACS Med Chem Lett，2016，7（8）：751-756. 2013.DOI：10.1016/j.ejmech.2013.08.054.
[36] BALLELL L，FIELD RA，DUNCAN K，et al. New small- （收稿日期：2019-03-22 修回日期：2019-06-21）
molecule synthetic antimycobacterials[J]. Antimicrob Agents （编辑：唐晓莲）
Chemother，2005，49（6）：2153-2163.

·2430 · China Pharmacy 2019 Vol. 30 No. 17 中国药房 2019年第30卷第17期